New Initiative for Theranostics and Particle Therapy launched
A key focus of the initiative will be translational research, or research that is designed to benefit human health. Investigators will assess how particle beam radiation may be effective to treat cancers that are difficult to treat using conventional radiation therapy, how diagnostic and treatment steps can be combined into a single step referred to as theranostics, and how radiation treatment plans can be personalized for each patient.
UW–Madison expert launches novel cancer research using sharks
There are some new residents on the University of Wisconsin–Madison campus, but they aren’t students, they’re sharks.
UW begins new clinical trial to treat fatal blood diseases in children, young adults
A clinical trial has launched at the UW School of Medicine and Public Health to test the safety of a new type of stem cell transplantation to treat a variety of deadly blood disorders in children and young adults.
Study finds analyzing DNA in urine could help detect cancer
A study published this week in Science Translational Medicine describes how urinalysis could potentially be used to detect some forms of cancer.
Thomas ‘Rock’ Mackie receives gold medal from radiation oncology society
Cancer research conference focuses on targeted radionuclide therapy
University of Wisconsin-Madison is hosting a national conference on targeted radionuclide therapy (TRT), a promising new technology that combines cytotoxic radioisotopes with molecularly targeted agents to produce an anti-cancer therapy capable of treating local or systemic disease.
Simultaneous infection by two viruses the key to studying rare lymphoma
New research has found that a rare blood cancer can be simulated in the lab only by simultaneously infecting white blood cells with two viruses typically found in the tumors.
Researchers probe cell division defects to gain insight into cancer
From bugs to plants to animals, for all living things to grow they must create more cells.
UW study provides potential treatment strategy for aggressive lymphoma
A research team at the University of Wisconsin Carbone Cancer Center has found a new tumor-causing mechanism that contributes to the development of the most common form of non-Hodgkin lymphoma.
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use antiangiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
Wisconsin researchers well-represented at international radiation oncology conference
The 60th annual meeting of the American Society for Radiation Oncology (ASTRO), the world’s premier radiation oncology society, got underway this week in San Antonio, Texas, with a strong Wisconsin presence.
Breast cancer expert Kari Wisinski joins Big Ten research leadership
Kari Wisinski, MD, a breast cancer specialist with the University of Wisconsin Carbone Cancer Center, has been named to the steering committee of the Big Ten Cancer Research Consortium.